Mi-Kyung Park Selected Research

ovalbumin-alum

1/2019	Adoptive transfer of Trichinella spiralis-activated macrophages can ameliorate both Th1- and Th2-activated inflammation in murine models.
1/2016	Preventive Intra Oral Treatment of Sea Cucumber Ameliorate OVA-Induced Allergic Airway Inflammation.
12/2014	Parasitic nematode-induced CD4+Foxp3+T cells can ameliorate allergic airway inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mi-Kyung Park Research Topics

Disease

17	Arthritis (Polyarthritis) 01/2016 - 01/2004
17	Rheumatoid Arthritis 07/2013 - 01/2004
16	Inflammation (Inflammations) 01/2019 - 01/2004
12	Experimental Arthritis 01/2016 - 06/2009
9	Neoplasms (Cancer) 02/2022 - 02/2005
8	Osteoarthritis 01/2013 - 01/2005
7	Infections 01/2022 - 04/2012
4	Respiratory Hypersensitivity 01/2019 - 01/2014
3	Hyperplasia 01/2019 - 01/2015
3	Asthma (Bronchial Asthma) 01/2017 - 08/2011
3	Breast Neoplasms (Breast Cancer) 07/2015 - 02/2005
3	Autoimmune Diseases (Autoimmune Disease) 08/2014 - 01/2010
2	Hypoxia (Hypoxemia) 04/2019 - 07/2013
2	Hypersensitivity (Allergy) 01/2019 - 03/2016
2	Virus Diseases (Viral Diseases) 09/2018 - 11/2006
2	Neoplasm Metastasis (Metastasis) 04/2005 - 02/2005
1	Esophageal Squamous Cell Carcinoma 02/2022
1	Parasitic Diseases (Parasitic Disease) 01/2022
1	Parasitemia 04/2019
1	Colitis 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Chronic Cough 03/2016
1	Heart Failure 05/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2014
1	Bone Diseases (Bone Disease) 05/2014
1	Fibrosis (Cirrhosis) 05/2014
1	Joint Diseases (Joint Disease) 05/2014
1	Visceral Larva Migrans 10/2013
1	Alzheimer Disease (Alzheimer's Disease) 10/2013
1	Behcet Syndrome (Behcet's Syndrome) 08/2013
1	Pain (Aches) 01/2013

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2022 - 01/2004
8	Interleukin-17 (Interleukin 17)IBA 10/2012 - 01/2004
5	InterleukinsIBA 03/2012 - 01/2005
4	Immunoglobulin E (IgE)IBA 03/2016 - 01/2014
4	AllergensIBA 03/2016 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2019 - 02/2007
3	ovalbumin-alumIBA 01/2019 - 12/2014
3	OvalbuminIBA 01/2019 - 12/2014
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2016 - 08/2011
3	AntioxidantsIBA 01/2016 - 06/2009
3	Immunoglobulin G (IgG)IBA 01/2016 - 01/2014
3	Collagen Type II (Type II Collagen)IBA 11/2014 - 03/2004
3	Interleukin-6 (Interleukin 6)IBA 07/2012 - 01/2004
3	NF-kappa B (NF-kB)IBA 03/2012 - 01/2004
3	proanthocyanidinIBA 01/2012 - 06/2009
3	Interleukin-8 (Interleukin 8)IBA 12/2010 - 01/2004
2	LigandsIBA 01/2022 - 04/2008
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2016
2	Interleukin-5 (Interleukin 5)IBA 01/2017 - 10/2013
2	Immunoglobulins (Immunoglobulin)IBA 03/2016 - 05/2015
2	EnzymesIBA 03/2016 - 01/2016
2	ImmunosorbentsIBA 03/2016 - 01/2016
2	Biological ProductsIBA 01/2016 - 07/2012
2	interleukin-21 (interleukin 21)IBA 08/2014 - 03/2012
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2014 - 12/2012
2	Interferon-gamma (Interferon, gamma)IBA 01/2013 - 09/2012
2	Monoclonal AntibodiesIBA 12/2012 - 04/2008
2	Vitamin A (Retinol)FDA LinkGeneric 11/2012 - 07/2012
2	Therapeutic UsesIBA 11/2012 - 06/2009
2	Retinaldehyde (Retinal)IBA 11/2012 - 09/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2012 - 04/2008
2	Macrophage Migration-Inhibitory FactorsIBA 09/2010 - 05/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 02/2004
2	Estrogens (Estrogen)FDA Link 01/2009 - 02/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2022
1	AntibodiesIBA 01/2022
1	Oxygen (Dioxygen)IBA 04/2019
1	Dextran SulfateIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Interferon Type IIBA 09/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Interleukin-13IBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2016
1	p300-CBP-associated factorIBA 07/2015
1	Transcription Factors (Transcription Factor)IBA 07/2015
1	Digoxin (Digitek)FDA LinkGeneric 05/2015
1	Cardiac GlycosidesIBA 05/2015
1	Dinoprostone (PGE2)FDA Link 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	Neutralizing AntibodiesIBA 01/2015
1	CCR5 Receptors (CCR5 Receptor)IBA 12/2014
1	Dual-Specificity PhosphatasesIBA 11/2014
1	AutoantibodiesIBA 08/2014
1	halofuginoneIBA 05/2014
1	Amyloid beta-PeptidesIBA 10/2013
1	Interleukin-33IBA 08/2013
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2013
1	phospholipase D1IBA 07/2013
1	Celecoxib (Celebrex)FDA Link 01/2013
1	Iodoacetic AcidIBA 01/2013
1	rebamipideIBA 01/2013
1	Interleukin-2 (IL2)IBA 12/2012

Therapy/Procedure

2	Intravenous Administration 01/2017 - 01/2014
2	Therapeutics 01/2017 - 01/2013
2	Ligation 03/2012 - 04/2009
1	Intraperitoneal Injections 04/2019
1	Oral Administration 01/2016